WO1995011012A1 - Produit cosmetique a l'epreuve de l'eau - Google Patents

Produit cosmetique a l'epreuve de l'eau Download PDF

Info

Publication number
WO1995011012A1
WO1995011012A1 PCT/EP1994/003459 EP9403459W WO9511012A1 WO 1995011012 A1 WO1995011012 A1 WO 1995011012A1 EP 9403459 W EP9403459 W EP 9403459W WO 9511012 A1 WO9511012 A1 WO 9511012A1
Authority
WO
WIPO (PCT)
Prior art keywords
matrix
water
forming material
active ingredient
oil
Prior art date
Application number
PCT/EP1994/003459
Other languages
German (de)
English (en)
Inventor
Claudia Hohmann
Detlef Koch
Werner Pflug
Original Assignee
Rotring International Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotring International Gmbh & Co Kg filed Critical Rotring International Gmbh & Co Kg
Publication of WO1995011012A1 publication Critical patent/WO1995011012A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/652—The particulate/core comprising organic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Definitions

  • the invention relates to a cosmetic composition, an aqueous dispersion containing this composition, a process for its production and its use as / in cosmetic product (s) or for the production of cosmetic products.
  • Conventional methods for making small, discrete, core-containing particles of hydrophobic polymer material include the step of polymerizing the monomer so as to form a core encapsulating polymer shell.
  • Sole nee Haina in US Pat. No. 4,421,660 describes how particles of inorganic solid such as TiO 2 having a colloidal size are encapsulated in a hydrophobic addition polymer such as polystyrene in a polymerization process, a water-insoluble hydrophobic monomer being contained in an aqueous, colloidal Dispersion of the inorganic particles is dispersed and then this mixture is subjected to an emulsion polymerization.
  • a hydrophobic addition polymer such as polystyrene
  • magnetic toner particles are produced by a vinyl monomer Polymerization initiator, magnetic particles and a solvent for the monomer as droplets in the form of a discontinuous phase are suspended in a continuous, aqueous phase. Then the monomers are polymerized in the discontinuous phase after removal of the solvent to form the polymer-coated toner particles.
  • suspension polymerization of a monomer is an essential part of the encapsulation process.
  • the conditions required for the polymerization of a surrounding monomer limit, for example, the range of usable concentration ratios of the enclosed component to the component forming the shell, the physical properties of the enclosed components and the possible choice of suitable auxiliaries such as surfactants.
  • the emulsion polymerization is a complex reaction and for every desired combination of materials and the resulting concentrations, research into suitable polymerization conditions is necessary.
  • Micale describes in US Pat. No. 4,665,107 the production of a polymer shell which lies tightly around solid particles (pigment) with a submicron size (> 1 ⁇ m) in order to form a low-viscosity writing fluid.
  • This liquid is produced by first dispersing the pigment submicron particles in an intermediate solvent, which also contains the encapsulating, water-insoluble polymer, and then dispersing the mixture in water and dissolving the intermediate solution. it will.
  • the polymer material is not changed significantly during the coating.
  • the first disadvantage is the economic outlay, which is necessary due to the additional step of removing the solvent and then cleaning the removed solvent for reuse or disposal.
  • the second disadvantage is that typical intermediate solvents such as methylene chloride tend to cause environmental problems and the removal of trace amounts of the solvent from the end product is necessary in order to protect the health of end consumers.
  • Methods are also known for producing capsules with active components enclosed therein, in which the capsule size is in the micrometer and submicrometer range.
  • Mivano et al. in US-A-3 856 699 describe a process for the production of capsules with walls made of wax-like material, in which a wax-like material, which contains a core material, in a moving aqueous medium at a temperature above the melting point of the wax-like material Material is dispersed dropwise and then the wax-like material is transferred to a still aqueous medium which is at a temperature points, which is lower than the melting temperature of the wax-like material.
  • the size of the droplets is controlled by the stirring speed and is a minimum of 20 to 500 ⁇ .
  • compositions are known in which a more or less thick film forms on the skin after use, which protects the applied active ingredient, for example, against premature and unintentional washing off by water.
  • DE 37 10 292 AI and DE 37 10 293 AI use polymer cellulose derivatives in particular to produce waterproof sun protection products that form waterproof films on the skin.
  • EP-A-0 356 196 describes a cosmetic preparation in which a film is formed on the skin from a stable oil-in-water emulsion and comprises a thin, flexible acrylate homopolymer layer and a sunscreen.
  • EP-A-0 265 228 describes a skin protection agent which comprises an acrylic copolymer of ethyl acrylate and methacrylic acid.
  • DE 25 44 180 describes a fat-containing cosmetic preparation which contains certain UV absorbers and ointment and cream bases or solvents which are used for the production of liquid sunscreen and skin care preparations. They are produced by stirring the components together and homogenizing them at temperatures of, for example, 75 ° C.
  • the known compositions and preparations have the disadvantage that they do not penetrate into the skin, or only to a small extent or superficially, so that the water resistance described in part does not last long.
  • the present invention is therefore based on the object of providing a cosmetic composition which is suitable as or for the production of cosmetic products, can be prepared without polymerisation processes and without the use of intermediate organic solvents which are to be removed later, after application of a permanent waterproof application of the active ingredient and can contain a variety of cosmetically active ingredients individually or in combination. If necessary, there is also a delayed delivery and thus. ' :. Longer lasting cosmetic effect of the enclosed substance.
  • a cosmetic composition which a) comprises a solid, particulate, water-insoluble matrix composed of at least one water-insoluble, non-polymeric, matrix-forming material which is solid at room temperature, and b) one which is enclosed in the matrix , Water-insoluble, cosmetically active ingredient, wherein the matrix particles have an average size of about 1 micron or less.
  • This cosmetic composition which can also be in the form of its aqueous dispersion, can be prepared by a process which is characterized in that 1) at least one water-insoluble, non-polymeric, matrix-forming material which is solid at room temperature , and a water-insoluble active constituent to be enclosed in the matrix are heated together to a temperature sufficient to melt the matrix-forming material, 2) the hot melt formed from the matrix-forming material and active constituent is added to water with agitation, optionally with surfactant being present is to produce a stable aqueous emulsion which comprises matrix-forming material with the active ingredient enclosed therein in the form of droplets with an average size of about 1 ⁇ m or less, and 3) the stable, aqueous emulsion is cooled to room temperature to form an aqueous dispersion of solid particles of matrix-forming material with active encapsulated therein
  • composition or dispersion according to the invention and the method according to the invention for their production is a significant improvement over the previously known compositions or methods.
  • the rheological and physical properties of the cosmetic composition or dispersion according to the invention are determined by the mass properties, morphology and the surface properties of the matrix-forming material and are therefore independent of the nature or type of the active ingredient included.
  • the matrix-forming material can be any material which is essentially insoluble in water, preferably less than 5%, preferably less than 3% and in particular less than 1% soluble in water, and is inert with respect to the active ingredient . It must be stable during heating, should preferably have a melting point below about 100 ° C. and form a melt which has a viscosity which is lower than about 600 mPas and preferably lower than about 500 mPas.
  • the matrix-forming material can be a solid, a liquid or a mixture of solids and liquid, which are usually solid at room temperature.
  • Suitable matrix-forming materials are vegetable oils, in particular hardened palm oil, hydrogenated triglycerides of coconut and oil palm, cotton oil, castor oil and esters thereof, animal waxes such as tallow, beeswax, whale wax or aqueous lanolin, fatty acids such as stearic acid, lauric acid or myristic acid, ester or amides of fatty acids such as ethylene glycol monostearate, propylene glycol monostearate and glycerol monostearate, sorbitan fatty klareester as sorbitan monopalmitate, sorbitan monostearate and sorbitan tristearate, fatty alcohols such as cetyl alcohol, ethoxylated fatty alcohols, triglycerides, such as triglycerides of vegetable oils or modified vegetable oils, petroleum or mineral waxes such as paraffin, alkylene glycols, in particular solid at room temperature ethylene glycols and propylene glycols.
  • stearic acid esters such as ethylene glycol and propylene glycol monostearate and sorbitan tristearate, and hydrogenated triglycerides of coconut and oil palm (e.g. Wecobee FS from Stepan).
  • the active component which is to be encapsulated or dissolved in the matrix-forming material, is characterized by an extremely low solubility in water and a high solubility in hydrophobic liquids or solvents. If the active ingredient is a solid submicron particle like a pigment, it should be in the melt of the matrix-forming material. rials can be dispersed without significant agglomeration. If the active component is a solid or a liquid, it is preferably soluble in the melt of the matrix-forming material and results in a homogeneous mixture in the matrix-forming material. The active ingredient is preferably a lipophilic liquid.
  • the vapor pressure of the active ingredient is sometimes low or the active ingredient is sometimes solid at room temperature and not soluble in the matrix-forming material of choice.
  • the active ingredient can also be in the form of particles that are too large to be successfully encapsulated. In such cases, the active ingredient can first be dissolved in a water-immiscible liquid which is capable of giving a homogeneous mixture with the molten matrix-forming component and then being allowed to remain in the dispersion.
  • Suitable carrier liquids include solvents such as tributyl citrate, dioctyl phthalate, pine oil, etc.
  • the active component encapsulated by the matrix-forming material is a) a solid particle with a size smaller than 1 ⁇ m (sub-micrometer particles), b) a solid or a liquid which is produced in the melt of the matrix-forming material or c) a solid or a liquid which has been dissolved in a carrier liquid which is immiscible with water during manufacture.
  • Suitable active ingredients include, for example, all coloring components, skin-care or skin-protecting components and fragrances. It is irrelevant whether the active ingredient as such is solid or liquid at room temperature. These include in particular the colorants approved for cosmetic products, especially those for lipsticks. Examples include fat-soluble dyes such as fat brown B (casella), various food dyes (such as the naturally-synthesized food coloring agent ß-carotene oil-soluble, liquid (E160a) from Riedel aroma), possibly on a natural basis, Pigments and pigment preparations.
  • fat-soluble dyes such as fat brown B (casella)
  • various food dyes such as the naturally-synthesized food coloring agent ß-carotene oil-soluble, liquid (E160a) from Riedel aroma
  • essential oils such as bergamot oil, Cedernholz- and -blattöl, citronella oil, eucalyptus oil, pine needle oil, Ka il- Lenoel, camphor, Kierfernnadelöl, spearmint, Latschenkie- remote oil, lavender oil, balm oil, Nelkenlux- and -blütenöl, orange oil, pepper oil, peppermint oil , Rose oil, cinnamon oil and lemon oil.
  • caring substances such as oil-soluble vitamins, avocado oil, jojoba oil, aloe vera extract in an oily preparation, panthenol, walnut oil, tocopherol (vitamin E), tocopherol acetate, hydrogenated peanut oil, sweet almond oil, wheat germ oil, coconut oil, soybean oil, calendula oil Evening primrose oil, various plant extracts based on soybean oil, castor oil, various perfume oils and biobranil (concentrated extract from wheat bran) are suitable.
  • oil-soluble vitamins avocado oil, jojoba oil, aloe vera extract in an oily preparation, panthenol, walnut oil, tocopherol (vitamin E), tocopherol acetate, hydrogenated peanut oil, sweet almond oil, wheat germ oil, coconut oil, soybean oil, calendula oil Evening primrose oil, various plant extracts based on soybean oil, castor oil, various perfume oils and biobranil (concentrated extract from wheat bran) are suitable.
  • Active ingredients such as butylmethoxydibenzoylmethane, benzophenone-3, menthylbenzylidene ca pher, octyl ethoxycinnamate, octyldimethyl-PABA (or 2-ethylhexyl-4-dimethylaminobenzoate) and isoamyl-p-methoxycinnamate are also suitable as sun protection components.
  • the active component encapsulated by the matrix-forming material is preferably a UV-absorbing material, an essential oil, an organic dye, an organic or inorganic pigment, a lubricating oil, a fragrance or a flavoring agent and is particularly selected from pine oil, peppermint oil , substituted or unsubstituted cinnamic acids or substituted or unsubstituted cinnamic acids esters, triazole Compounds, organic dyes, inorganic pigments, perfume oils, derivatives of ⁇ -linolenic acid, vitamins such as vitamins E and A or skin softening agents.
  • the active ingredient is therefore preferably, for example, a colorant for a wide range of dyeing or coating applications or a chemical which is to be released in a controlled manner, for example to improve breathing or to keep the skin moist.
  • Suitable active ingredients include UV absorbing materials such as substituted or unsubstituted cinnamic acids and their esters, formamidine compounds, triazole compounds and those compounds which are used as optical brighteners, and organic and inorganic dyes, organic and inorganic pigments such as micronized titanium dioxide, micronized zinc oxide and iron ferrocyanide, lubricating oils such as skin softening agents, fragrances and substances such as perfume oils (for example lavender, pine oil, clove oil, peppermint oil and the like).
  • the active ingredient can be present in widely varying concentrations, but the ratio of active ingredient to encapsulating matrix material is preferably in the range from about 1:25 to 25: 1, preferably 1:10 to 10: 1. If a carrier is used, in order to dissolve the active ingredient, the active ingredient should preferably be present in the carrier in a concentration of about 0.5 to 95% by weight, preferably 1 to 90% by weight and more preferably 2 to 85% by weight.
  • the active ingredient is typically insoluble in water, but is soluble in the matrix-forming material so that it does not pass into the aqueous phase when an aqueous emulsion or dispersion is formed.
  • the matrix-forming material used influences the emulsion and dispersion behavior in water and serves to store, protect and transport the active component in an environment in which it would otherwise be would not be stable at all or only to a limited extent due to solubility, oxidation or other factors.
  • An essential feature of the present invention is therefore also that the active ingredient, when embedded or encapsulated in the matrix-forming material, can be stable in an aqueous solution and cannot be released before the particle is placed in a suitable, e.g. lipophilic, environment arrives.
  • the active ingredient may be due to physical forces that are exerted when the composition is applied to the desired substrate, e.g. the skin to be applied are released from the matrix-forming material.
  • the active ingredient can be released by evaporation after removal of the surrounding water.
  • it can be released from the matrix-forming material after a change in the chemical, biological or physical environmental conditions. The release can therefore possibly include mechanisms such as diffusion through the matrix material and / or increased solubility of either the active component or the matrix material in the target environment.
  • Suitable substrates to which the composition according to the invention or the dispersion according to the invention can be applied include, for example, human skin, fingernails and toenails or hair substrates.
  • the cosmetic compositions or dispersions according to the invention can serve as such as cosmetic preparations or can be used to produce such preparations.
  • particles in the submicron range (size ⁇ 1 ⁇ m) are produced which contain an active ingredient which is stored, stabilized or stabilized in a hydrophilic, ie water-containing environment can be transported and then released by deliberate change of environment.
  • the particles can be formulated in such a way that they show the desired surface and physical properties, which in turn are independent of the chemical or physical properties of the enclosed active ingredient.
  • the active ingredient is preferably evenly distributed in the matrix material or surrounded by the matrix material as a shell.
  • the rheology and the ability to control the dispersion stability with respect to both the flocculation and the suspension of the submicroscopic, dispersed particles is significantly improved overall.
  • the stability and the rheological properties of an aqueous dispersion are therefore largely predictable, and knowledge of the physical and chemical properties of the matrix-forming material can be used, these properties not being significantly influenced by the nature or the amount of the active ingredient .
  • the active ingredient is a skin-penetrating and moisturizing compound that is to be applied to the skin and then mediated through a lipophilic delivery system
  • higher concentrations of this compound are possible than when water-based delivery systems are used, which is based on the solubility limits in water.
  • the particles can be formulated more easily so that they show the desired properties, such as, for example, the particle sizes, film-forming properties or adhesive properties, and properties such as gloss and abrasion resistance.
  • the present invention provides acceptable physical and chemical Properties of the active ingredient, desirable ratios of active ingredient to the matrix-forming material and the choice of suitable matrix-forming materials larger areas.
  • the present invention enables these advantages without the need for an intermediate solvent and the associated need for removal and disposal.
  • matrix-forming materials are used which can easily be formulated in such a way that they can control the release rate of an enclosed active component in a targeted manner.
  • a possible explanation for this phenomenon is that the diffusion rate of an active component through the surrounding matrix can be controlled primarily by the physical interaction of the active component with the matrix material.
  • composition particles of matrix and active ingredient have a size smaller than 1 ⁇ m and preferably an average size of 500 to 5 nm, in particular 200 to 5 nm or even less.
  • the ratio of active ingredient to matrix-forming material is preferably in the range from 0.04 to 25, more preferably 0.1 to 10, which corresponds to a ratio of 1:25 to 25: 1, more preferably 1:10 to 10: 1.
  • the solid particles of matrix material and the active ingredient enclosed therein can be dispersed in an aqueous medium and accordingly form an aqueous dispersion which can be used as or for the production of cosmetic products.
  • the aqueous dispersion then preferably comprises 1.0 to 50% by weight, in particular 10 to 40 and preferably 20 to 30% by weight, of the solid, particulate cosmetic composition according to the invention as a discontinuous phase and, if appropriate, surfactant.
  • Suitable surfactant material which can be used according to the invention comprises anionic, cationic, amphoteric and non-ionic surfactants or mixtures thereof.
  • Suitable surfactants include non-ionic surfactants such as polyethylene oxides, ethoxylated alkylphenols (eg nonylphenol polyoxyethylene), ethoxylated fatty acid esters, ethoxylated fatty alcohols (eg cetyl, stearyl, lauryl or tridecyl alcohol), ethoxylated glyceride esters, sorbitan esters (eg sorbitan tristearate) ), long-chain fatty acid esters from polyethylene glycols, diethanolamides, coconut fatty acid monoethanolamide, alkylaryl polyether alcohols, etc.
  • non-ionic surfactants such as polyethylene oxides, ethoxylated alkylphenols (eg nonylphenol polyoxyethylene), ethoxylated fatty acid esters, ethoxylated fatty alcohols (eg cetyl, stearyl, lauryl or tridecyl alcohol), ethoxylated glyceride est
  • Usable anionic surfactants include sodium lauryl sulfate, sulfosuccinic acid derivatives (eg disodium N-octadecylsulfosuccinate, disodium ethoxylated alcohol half ester of sulfosuccinic acid, disodium ethoxylated nonylphenol half ester of sulfosuccinic acid, diamyl ester of sodium sulfosuccinate sulfonate), diamyl ester of sodium sulfosuccinate sulfonate (I) Alcohol esters (for example ammonium salts of sulfated nonylphenoxy poly (ethylene oxy) ethanol), ammonium lignin sulfonate, lecithin and naturally occurring mixtures of diglycerides of stearic, palmitic and oleic acids which are linked to the quinoline ester of phosphonic acids.
  • Useful cationic surfactants include quaternary ammonium salts, cetyl pyridinium chloride, polyalkylamidoimidazoline sulfate and ethanolized alkylguanidine amine complexes.
  • Usable amphoteric surfactants include complex fatty amide compounds, modified fatty amine condensates and sulfobetaine compounds. Of these surfactants, non-ionic and anionic surfactants are preferred, in particular those selected from ethoxylated alkylphenols, ethoxylated alcohols.
  • the first stage of the process comprises heating at least one water-insoluble, non-polymeric, matrix-forming material which is solid at room temperature and a water-insoluble, cosmetic, active ingredient to be encapsulated in the matrix. Heating is continued until a temperature is reached which is sufficient to melt the matrix-forming material, but is preferably lower than about 100 ° C., so as to form a hot melt which has a viscosity which is lower than about 500 mPas.
  • the temperature is preferably kept in a range from about 60 to about 85 ° C., and again the mixture is preferably stirred with a mechanical stirrer during the heating.
  • the matrix-forming material essentially determines the density of the aqueous emulsion. Concentration ratios can be produced in a wide range in the aqueous emulsion in a simple manner by changing the ratios of the active ingredient to the matrix-forming material accordingly.
  • the ratio of active ingredient to matrix-forming material is preferably in the range from about 0.1 to 10.0.
  • the density of the composition particles obtained in the end is a function of this ratio and the density of the matrix-forming material.
  • the active ingredient is dissolved in the hot liquefied melt of the matrix-forming material and dispersed therein.
  • at least one surfactant is added to the hot melt before the melt is added to water in step 2).
  • the choice of surfactant, if used, depends essentially on the chemistry and surface properties of the active ingredient. However, a wide variety of surfactants can be used as long as they have the ability to wet the active ingredient in the hot melt or to reduce the interfacial tension between the hot melt and the water in stage 2).
  • the hot melt After heating in stage 1), the hot melt is added to water in an amount such that a concentration in the range of preferably 1 to 50% by weight, in particular 10 to 40% by weight and more preferably 20 to 30% by weight results.
  • the surfactant which is optionally present when the hot melt is added to water while moving (stage 2), can be combined with the hot melt, previously added to the water to which the hot melt is added, or both . At least one surfactant is preferably combined with the hot melt in stage 1) and then another surfactant or an additional amount of the same surfactant is added to the water to which the hot melt is added.
  • the aqueous phase should be at the same temperature level in order to avoid a "temperature shock".
  • a surfactant is added to the water, it can be added either before or simultaneously with the addition of the hot melt.
  • the presence of a surfactant when added in stage 2) is advantageous in order to reduce the interfacial tension between the hot melt and the water to a value of less than about 10 dynes / cm, preferably less than 5 dynes / cm , which further facilitates the production of a stable aqueous emulsion.
  • suitable aqueous emulsions are typically prepared if the relative concentrations fall into the following ranges, the data being based on 100 g of the particle emulsion:
  • matrix-forming material such as, for example, propylene glycol monostearate and sorbitan tristearate, a total of about 0.1 to about 50 g,
  • active ingredient such as liquid pine oil or a solid dissolved in a suitable solvent, a total of about 0.1 to about 50 g,
  • Surfactant such as sorbitan tristearate from about 0 to about 25 g and
  • Water optionally containing up to about 10% additional surfactant such as disodium ethoxylated alcohol half ester of sulfosuccinic acid, at least 40 g.
  • additional surfactant such as disodium ethoxylated alcohol half ester of sulfosuccinic acid, at least 40 g.
  • the sufficient movement of the hot melt in the water during the emulsification in stage 2) can be achieved by a number of commercially available devices such as, for example, ultrasound devices, in particular ultrasound heads, high-speed stirrers, mixers or suitable homogenizers.
  • the agitation is caused by ultrasound in order to obtain an aqueous emulsion with very small droplets.
  • the droplet size in the aqueous emulsion obtained is on average smaller than 1 ⁇ m, preferably is on average 500 to 5 nm, more preferably 200 to 5 nm or even less.
  • the aqueous emulsion should be stable for at least two hours after it is made.
  • the aqueous emulsion has a stable discontinuous phase, which has an average size of less than 1 ⁇ m, and a continuous aqueous phase (water).
  • the time required to produce the desired droplet size varies with the type of device used, the amount of hot melt and water used and the interfacial tension between the hot melt and water. In general, a time of at least two minutes, preferably about four minutes, is required if ultrasound is used, an average drop size of ⁇ 1 ⁇ can be achieved and 100 g are to be treated. In a preferred embodiment, the drops have an effective average size of approximately 500 nm or less, more preferably approximately 200 n or less and particularly preferably approximately 5 nm or less, which is achieved by means of an electron microscope, laser diffraction or on the basis of the zeta determined Potential can be demonstrated.
  • a subsequent lowering of the temperature of the system to, for example, room temperature leads to the solidification of the emulsion drops and the formation of spherical solid matrix particles which contain the active ingredient.
  • the cooling in stage 3) is preferably carried out at a cooling rate of about 0.5 to 15 ° C., in particular 1 ° C. to about 10 ° C. and preferably 2 to 5 ° C. per minute.
  • the cooling is achieved, for example, by simply allowing the aqueous emulsion to cool to room temperature, actively cooling it from the outside, or cooling it internally by adding additional water, this added water having a lower temperature than the emulsion.
  • the particles formed in this way are stable with regard to flocculation and sedimentation, show good dispersibility and, like before, the droplets have an average particle size. diameters of less than about 1 ⁇ m, preferably in the size range from about 5 to 500 nm, more preferably in the range from about 5 to 200 nm, and in some cases are even smaller. Furthermore, at least one particle of the active ingredient is preferably present as a core in each matrix particle or it is dissolved in the matrix material.
  • stages 1), 2) and 3) can be carried out under controlled pressure conditions if this is suitable, which is the case if a volatile active component is used.
  • all stages or each of the stages can be carried out under a suitable inert gas such as nitrogen, helium or argon if the active ingredient is sensitive to oxygen.
  • the exact formulation determines the release rate of the active ingredient in response to changes in the environment.
  • the diffusion rate is influenced by the solubility of the active constituent in the matrix-forming material, the ratio of matrix-forming material to active constituent, the solubility of active constituent under changed ambient conditions and the rate of degradation of the matrix.
  • the size of the particles is directly related to the total surface area of the particles that is available for release. The particle size could be a function of the amount of surfactant used, which additionally controls the interfacial tension between the hot melt and the water, and the amount of energy necessary to obtain a desired degree of emulsion of the hot melt in the water.
  • the active ingredient can be released into a desired environment in a controlled manner by one or more of the following mechanisms:
  • Matrix material as a function of its solubility in the surrounding medium, for example in the case of fat or similar lipophilic substrates, or
  • Propylene glycol monostearate 1.0 to 25% by weight 10.0 to 15.0% by weight 11.00% by weight %
  • Sorbitan tristearate 1.0 to 25% by weight 10.0 to 15.0% by weight 14.95% by weight
  • active ingredient 0.5 to 50% by weight 10.0 to 30.0% by weight 20.00% by weight
  • POE (20) sorbitan monolaurate can affect the feeling on the skin. POE (20) sorbitan monolaurate and disodium ethoxylated half ester of sulfosuccinic acid are not necessary components.
  • the matrix material is heated until all components have melted.
  • the active ingredient is added and the mixture is homogenized by stirring.
  • the dispersion medium is preheated to 75 ° C., the head of an ultrasonic homogenizer is immersed in it at this temperature and the mixture of matrix material and active ingredient is slowly added.
  • treatment is carried out with ultrasound (350 W, 20-40% output power).
  • the mixture is cooled to room temperature without further ultrasound treatment and, if necessary, with gentle stirring.
  • Example 1 (Facial Moisturizing Cream) The following constituents were processed into a cosmetic dispersion.
  • Part A deionized water 24.10% by weight
  • Methyl paraben 0.20% by weight
  • Triethanolamine 99% 0.60% by weight
  • Part C fragrances and preservatives to 100% by weight
  • Part A The ingredients of Part A except triethanolamine were mixed and dispersed. The triethanolamine was then added. Part B was added with vigorous stirring. Part C was then added and stirring continued until a homogeneous dispersion was obtained. Part B :
  • the components listed under 2) were heated together until they had completely melted. Then the mineral oil mentioned under 1), which had been preheated to 75 ° C., was added and a homogenized mixture was prepared with stirring. The mixture of 1) and 2) was slowly added to the mixture of the components under 3), which had been preheated to 80.degree. Then gently stirred for 5 minutes and cooled to 35 ° C.
  • Example 2 Liquid, tinted lotion (o / w emulsion for oily skin)
  • the following constituents were processed to give a cosmetic dispersion.
  • Part B deionized water 3.00 wt% glycerin 2.00 wt%
  • Part C pigmented dispersion 40.00% by weight
  • Part D deionized water 23.50% by weight
  • Part A The ingredients of Part A were mixed together while heating to 70 ° C.
  • the deionized water from part D was also heated to 70 ° C. and added to part A. It was cooled, with homogenization by stirring. Thereafter, the mixed ingredients of Part B were added with stirring and when a temperature of 30 to 35 ° C was reached.
  • the Dis ⁇ persion of Part C was added subsequently with stirring so that a homogeneous formulation was formed. In the end, fragrances and preservatives were added.
  • Sorbitan tristearate 14.50% by weight
  • Titanium dioxide 5.00% by weight
  • Iron oxides 3.50% by weight
  • Sulfosuccinic acid 1.50% by weight
  • the components of part 1) were heated together until they had completely melted.
  • the components of part 2) were ground as necessary and dispersed in part 1) using an ultrasonic homogenizer.
  • the constituents of part 3) were preheated together to 80 ° C. and then slowly mixed with the homogeneous mixture of part 1) and part 2), an immersed ultrasound head causing the desired dispersion. The dispersion was then cooled to ambient temperature with gentle stirring.
  • Example 3 (sunscreen lotion; o / w emulsion) The following constituents were processed into a cosmetic dispersion.
  • Part B stearic acid 3.00% by weight
  • Part B The components of Part B were heated to 85 ° C while stirring with a planetary stirrer. Part C was then added and a homogeneous mixture was prepared with continued stirring. A mixture of the components of Tei-D preheated to 75 ° C. was then also added with stirring. It was then cooled to 40 ° C and part E and optionally Water added to compensate for any loss of water. While cooling to ambient temperature, part A was stirred in, resulting in a homogeneous dispersion.
  • part 2 The components of part 2) were heated until they had completely melted.
  • This homogeneous mixture was added to part 3), which had been preheated to 80 ° C., and was dispersed by means of an ultrasound head. The mixture was then cooled to ambient temperature with gentle stirring.
  • the emulsion was prepared by adding the hot melt to water while sonicating. The temperature was kept between 60 and 75 ° C. After a 4-minute ultrasound treatment, droplets with an average diameter of less than 500 nm were found. The aqueous emulsion was then slowly cooled to room temperature, causing the droplets to solidify.
  • the dispersion of the solid particles was applied to a substrate.
  • the scent was retained for a significantly longer time.
  • UV absorber The following compounds were mixed by the process of the preceding example:
  • Palmitic and stearic acids 11.0% by weight of purified, hardened palm oil, 15.0% by weight of 2-ethylhexyl p-methoxycinnamate, 64.6% by weight of demineralized water and 1.2% by weight of disodium ethoxylated alcohol half-ester from
  • Example 6 (Essential Oils) Following the procedure of the previous examples, the following compounds were mixed:
  • the heating and emulsification were carried out in accordance with the method described above.
  • the scent of the essential oil remained much longer than with a standard oil-in-water emulsion of the same concentration.
  • Example 8 Scent dispenser (liquid, active ingredient)) 15 g of a solid, hydrogenated vegetable oil (commercially available from Stepan Co. under the trade name WECOBEE SS) and 5.0 g of solid stearic acid (commercially available from Eastman Kodak Comp. ) were weighed into a vessel. To this was added 10.0 g of lavender essence (commercially available from Reynaud Ltd. under the trade name R 152). The container was tightly sealed so that no volatile component could escape.
  • an ultrasonic homogenizer was added to the water mixture and the liquefied mixture of lavender oil / vegetable oil matrix was slowly added. An emulsion of the lavender / vegetable oil mixture formed in the water. An ultrasound sonication was carried out until a microscopic inspection showed that the emulsion drop size was uniform and below 1 ⁇ m. The emulsion was then gently stirred until the liquid reached room temperature, causing the lavender / vegetable oil mixture to solidify and a stable dispersion to result.
  • the dispersion was useful for making water-based cosmetics. It provided a pleasant smell for a long time, which was much longer than that obtained with an unencapsulated lavender oil.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Cosmetics (AREA)

Abstract

Des compositions cosmétiques et les dispersions qui les contiennent comprennent (a) une matrice solide particulaire insoluble dans l'eau constituée d'au moins un matériau non polymère insoluble dans l'eau, qui forme une matrice et qui est solide à la température ambiante, et (b) un principe actif à effet cosmétique insoluble dans l'eau et enveloppé par la matrice. Les particules qui constituent la matrice ont une grandeur moyenne égale ou inférieure à 1 νm. L'invention concerne également un procédé de préparation de ces compositions et de ces dispersions cosmétiques et leur utilisation.
PCT/EP1994/003459 1993-10-21 1994-10-21 Produit cosmetique a l'epreuve de l'eau WO1995011012A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4336407.1 1993-10-21
DE19934336407 DE4336407A1 (de) 1993-10-21 1993-10-21 Wasserfeste Kosmetik

Publications (1)

Publication Number Publication Date
WO1995011012A1 true WO1995011012A1 (fr) 1995-04-27

Family

ID=6500989

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1994/003459 WO1995011012A1 (fr) 1993-10-21 1994-10-21 Produit cosmetique a l'epreuve de l'eau

Country Status (2)

Country Link
DE (1) DE4336407A1 (fr)
WO (1) WO1995011012A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756478A1 (fr) * 1994-04-22 1997-02-05 Sunsmart, Inc. Compositions composites d'ecran total contre les ultraviolets
JP2012500777A (ja) * 2008-06-23 2012-01-12 インターナショナル フローラ テクノロジーズ，リミテッド 水素添加長鎖トリグリセリド油を含み、硬質粒子から軟質粒子に変化する化粧用粒子

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19837191A1 (de) * 1998-08-17 2000-02-24 Henkel Kgaa Kosmetische und dermatologische Hautbehandlungsmittel
NO20002309L (no) * 1999-05-12 2000-11-13 Hoffmann La Roche Fotostabile kosmetiske lysavskjermende sammensetninger
DE19958521A1 (de) * 1999-12-04 2001-06-07 Cognis Deutschland Gmbh Verwendung von nanoskaligen Wachsen
DE10007322A1 (de) * 2000-02-17 2001-08-23 Cognis Deutschland Gmbh Perlglanzmittel
DE10059668A1 (de) * 2000-12-01 2002-06-20 Henkel Kgaa Verwendung von nanopartikulären Wachsen in der Hautkosmetik
DE10238450A1 (de) * 2002-08-22 2004-03-04 Beiersdorf Ag Zubereitung zur Behandlung von Fehlpigmentierungen der Haut
DE10353030A1 (de) * 2003-11-13 2005-07-07 Beiersdorf Ag Konservierende Wirkstoffkombination
DE102005045147A1 (de) * 2005-09-16 2007-03-29 Beiersdorf Ag Kosmetische Zubereitungen zur dekorativen Anwendung auf der Haut
IT202000004816A1 (it) * 2020-03-06 2021-09-06 Alpha Biopesticides Ltd Composizione pesticida per la cura e la protezione delle coltivazioni

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375520A1 (fr) * 1988-12-20 1990-06-27 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Composition cosmétique ou pharmaceutique contenant des microsphères de polymères ou de corps gras chargées d'au moins un produit actif
EP0376852A1 (fr) * 1988-12-29 1990-07-04 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Microgranulés chargés en une substance active, constitués essentiellement d'un triglycéride d'acides gras saturés et leur utilisation par voie topique dans le domaine thérapeutique
EP0463962A1 (fr) * 1990-06-26 1992-01-02 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Procédé de préparation de microsphères de corps gras chargées ou non chargées en une substance active
EP0506197A1 (fr) * 1991-03-25 1992-09-30 Yamanouchi Europe B.V. Préparation topique contenant une suspension de particules lipidiques solides
WO1993005768A1 (fr) * 1991-09-18 1993-04-01 Medac Gesellschaft Für Klinische Spezialpräparate Gmbh Excipient constitue de particules lipidiques solides dites nanospheres lipidiques solides (sln)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856699A (en) * 1969-08-08 1974-12-24 Fuji Photo Film Co Ltd Process for producing capsules having walls of a waxy material
US4421660A (en) * 1980-12-15 1983-12-20 The Dow Chemical Company Colloidal size hydrophobic polymers particulate having discrete particles of an inorganic material dispersed therein
US4665107A (en) * 1986-03-21 1987-05-12 Koh-I-Noor Rapidograph, Inc. Pigment encapsulated latex aqueous colorant dispersions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375520A1 (fr) * 1988-12-20 1990-06-27 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Composition cosmétique ou pharmaceutique contenant des microsphères de polymères ou de corps gras chargées d'au moins un produit actif
EP0376852A1 (fr) * 1988-12-29 1990-07-04 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Microgranulés chargés en une substance active, constitués essentiellement d'un triglycéride d'acides gras saturés et leur utilisation par voie topique dans le domaine thérapeutique
EP0463962A1 (fr) * 1990-06-26 1992-01-02 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Procédé de préparation de microsphères de corps gras chargées ou non chargées en une substance active
EP0506197A1 (fr) * 1991-03-25 1992-09-30 Yamanouchi Europe B.V. Préparation topique contenant une suspension de particules lipidiques solides
WO1993005768A1 (fr) * 1991-09-18 1993-04-01 Medac Gesellschaft Für Klinische Spezialpräparate Gmbh Excipient constitue de particules lipidiques solides dites nanospheres lipidiques solides (sln)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756478A1 (fr) * 1994-04-22 1997-02-05 Sunsmart, Inc. Compositions composites d'ecran total contre les ultraviolets
EP0756478A4 (fr) * 1994-04-22 1999-04-14 Sunsmart Inc Compositions composites d'ecran total contre les ultraviolets
JP2012500777A (ja) * 2008-06-23 2012-01-12 インターナショナル フローラ テクノロジーズ，リミテッド 水素添加長鎖トリグリセリド油を含み、硬質粒子から軟質粒子に変化する化粧用粒子

Also Published As

Publication number Publication date
DE4336407A1 (de) 1995-04-27

Similar Documents

Publication Publication Date Title
DE69214425T2 (de) Langwirkende topische zusammensetzung für kosmetische und/oder pharmazeutische anwendung auf der äusseren schicht der haut
DE69600008T2 (de) Säurezusammensetzung basiert auf Lipidvesikeln sowie seiner Anwendung zur topischen Verwendung
DE60124028T2 (de) Mikrokapseln mit wässrigem Kern, der mindestens einen wasserlöslichen kosmetischen oder dermatologischen Wirkstoff enthält, und kosmetische oder dermatologische Zusammensetzungen, die sie enthalten
DE60028468T2 (de) Mikrokapsel und Verfahren zu derer Herstellung
DE69500034T2 (de) Lagerstabile, fluide und/oder fluidisierbare kosmetische Sonnenschutzmittel
EP0930866B1 (fr) Gels cosmetiques ou dermatologiques a base de microemulsions
DE69926862T2 (de) Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
DE69024518T2 (de) Emulgatorfreie Hand- und Körperlotion
DE69112601T2 (de) Emulsionszusammensetzung.
DE69831643T2 (de) Abriebfeste Kosmetikzusammensetzung enthaltend eine Kunststoffdispersion in einer flüssigen Ölphase und ein fettlösliches Polymer
DE3882906T2 (de) Feine Weichmikrokapseln enthaltendes kosmetisches Präparat.
DE60201394T2 (de) Wasserlösliche Verpackung aus einer Kapsel enthaltende Folie
EP0731685B2 (fr) Emulsion x/o/y multiple stable
DE3784803T2 (de) Verfahren zur herstellung von mikrokapseln, die polymer-dickungsoel enthalten.
EP1294479B1 (fr) Procede de production de capsules contenant une matiere active et a paroi ultramince
DE69202827T2 (de) Kosmetische Mittel in Form von wässerigen Organopolysiloxan-Emulsionen.
DE3872450T2 (de) Kosmetikum des wasser-in-oel-typs.
DE3710292A1 (de) Wasserfeste sonnenschutz-zusammensetzung
EP0615748A1 (fr) Matrices galénique de préférence sous forme de microsphères
DE19726184A1 (de) Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten
JPH10298051A (ja) 水中油滴型エマルジョンと抗日光用組成物およびエマルジョンの製造方法
WO1995011012A1 (fr) Produit cosmetique a l'epreuve de l'eau
DE602004013016T2 (de) Emulsionen mit einer konzentrierten inneren ölphase
DE69124093T2 (de) Herstellung diskreter mikrotropfen bestehend aus einer öl/wasseremulsion, stabilisiert durch in-situ polymerisation eines wasserlöslichen vinylmonomers
US6123960A (en) Composition based on lipid vesicles and a cross-linked poly(2-acrylamido-2-methylpropane-sulphonic acid) which is at least 90% neutralized

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase